Paul Kim

Dr. Paul Kim is the Chief Development Officer or Locus Biosciences. Paul is an experienced leader in the pharma/biotech industry spending over 17 years in drug development and commercialization. He has expertise in project and portfolio management, and has worked extensively leading cross-functional asset development teams at all phases of drug development including several global regulatory submission efforts. Paul has also worked with both large and small sized companies as well as helped organizations manage periods of significant growth and change.

Paul received a bachelors degree in biology and genetics at the University of British Columbia and his graduate degree in Cellular and Molecular Pathology from Vanderbilt University specializing in neuropathology. He formerly held the position of Vice President of Program Management at Puma Biotechnology where he recently provided project management oversight to the recent NDA and MAA regulatory submissions and currently provides portfolio level oversight to development stage projects and is the executive sponsor in charge of leading the build-out of Puma’s commercialization business systems infrastructure to support their first successful product launch.